Hypertension, hypertriglyceridemia, and impaired endothelium-dependent vascular relaxation in mice lacking insulin receptor substrate-1

Journal of Clinical Investigation

Volumn 101, Issue 8, 1998, Pages 1784-1788

  Abe, Hideki ^a   Yamada, Nobuhiro ^a   Kamata, Katsuo ^d   Kuwaki, Tomoyuki ^c   Shimada, Masako ^b   Osuga, Junichi ^b   Shionoiri, Futoshi ^b   Yahagi, Naoya ^b   Kadowaki, Takashi ^b   Tamemoto, Hiroyuki ^b   Ishibashi, Shun ^b   Yazaki, Yoshio ^b   Makuuchi, Masatoshi ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c CHIBA UNIVERSITY   (Japan)

^d HOSHI UNIVERSITY   (Japan)

Author keywords

Endothelium dependent vascular relaxation; Hypertension; Hypertriglyceridemia; Insulin receptor substrate 1; Insulin resistance

Indexed keywords

INSULIN RECEPTOR SUBSTRATE 1; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY RISK; FEMALE; HYPERTENSION; HYPERTRIGLYCERIDEMIA; INSULIN RESISTANCE; LIPOLYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL; VASODILATATION;

EID: 0032523085     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI1594     Document Type: Article

References (39)

1. Sun, X.J., P. Rothenberg, C.R. Kahn, J.M. Backer, E. Araki, P.A. Wilden, D.A. Cahill, B.J. Goldstein, and M.F. White. 1991. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature. 352:73-77.
2. Kadowaki, T., S. Koyasu, E. Nishida, K. Tobe, T. Izumi, F. Takaku, H. Sakai, I. Yahara, and M. Kasuga. 1987. Tyrosine phosphorylation of common and specific sets of cellular proteins rapidly induced by insulin, insulin-like growth factor I, and epidermal growth factor in an intact cell. J. Biol. Chem. 262:7342-7350.
3. Tamemoto, H., T. Kadowaki, K. Tobe, T. Yagi, H. Sakura, T. Hayakawa, Y. Terauchi, K. Ueki, Y. Kaburagi, S. Satoh, et al. 1994. Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1. Nature. 372: 182-186.
4. Araki, F., M.A. Lipes, M.E. Patti, J.C. Bruning, B. Haag III, R.S. Johnson, and C.R. Kahn. 1994. Alternative pathway of insulin signaling in mice with targeted disruption of the IRS-1 gene. Nature. 372:186-190.
5. Kaplan, N.M. 1989. The deadly quartet. Arch. Intern. Med. 149:1514-1520.
6. Reaven, G.M. 1988. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 37:1595-1607.
7. Zavaroni, I., E. Bonora, M. Pagliara, E. Dall'Aglio, L. Luchetti, G. Buonanno, P.A. Bonati, M. Bergonzani, L. Gnudi, M. Passeri, and G. Reaven. 1989. Risk factors for coronary artery disease in healthy persons with hyperinsuline-mia and normal glucose tolerance. N. Engl. J. Med. 320:702-706.
8. Abe, H., Y. Bandai, M. Makuuchi, Y. Idezuki, M. Nozawa, T. Oka, J. Ohsuga, Y. Watanabe, T. Inaba, and N. Yamada. 1996. Hyperinsulinemia accelerates accumulation of cholesterol ester in aorta of rats with transplanted pancreas. Diabetologia. 39:1276-1283.
9. Yamakoshi, K., H. Shimazu, and T. Togawa. 1979. Indirect measurement of instantaneous arterial blood pressure in the rat. Am. J. Phvsiol. 237:H632-H637.
10. Kurihara, Y., H. Kurihara, H. Suzuki, T. Kodama, K. Maemura, H. Nagai, T. Kuwaki, W.H. Cao, N. Kamada, K. Jishage, et al. 1994. Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature. 368:703-710.
11. Kamata, K., M. Sugiura, S. Kojima, and Y. Kasuya. 1996. Preservation of endothelium-dependent relaxation in cholesterol-fed and streptozotocin-induced diabetic mice by the chronic administration of cholestyramine. Br. J. Pharmacol. 118:385-391.
12. Miyata, N., K. Tsuchida, S. Okuyama, S. Otomo, K. Kamata, and T. Kasuya. 1992. Age-related changes in endothelium-dependent relaxation in aorta from genetically diabetic WBN/Kob rats. Am. J. Physiol. 262:H1104-H1109.
13. Shimano, H., N. Yamada, N. Katsuki, M. Shimada, T. Goloda, K. Harada, T. Murase, C. Fukazawa, F. Takaku, and Y. Yazaki. 1992. Overexpression of apolipoprotein E in transgenic mice: a marked reduction in plasma lipoproteins except high density lipoprotein. Proc. Natl. Acad. Sci. USA. 89:1750-1754.
14. Nilsson-Ehle, P., and M.C. Schotz. 1976. A stable, radioactive substrate emulsion for assay of lipoprotein lipase. J. Lipid Res. 17:536-541.
15. Shimada, M., H. Shimano, T. Gotoda, K. Yamamoto, M. Kawamura, T. Inaba, Y. Yazaki, and N. Yamada. 1993. Overexpression of human lipoprotein lipase in transgenic mice. J. Biol. Chem. 268:17924-17929.
16. Williams, B. 1994. Insulin resistance: the shape of things to come. Lancet. 344:521-524.
17. Yamauchi, T., K. Tobe, H. Tamemoto, K. Ueki, T. Kaburagi, R. Yamamoto-Honda, Y. Takahashi, F. Yoshizawa, S. Aizawa, Y. Akanuma, et al. 1996. Insulin signaling and insulin actions in the muscles and livers of insulin-resistant, insulin receptor substrate 1-deficient mice. Mol. Cell. Biol. 16:3074-3084.
18. Modan, M., H. Halkin, S. Almog, A. Lusky, A. Eshkil, M. Shefi, A. Shitrit, and Z. Fuchs. 1985. Hyperinsulinemia: a link between hypertension, obesity and glucose intolerance. J. Clin. Invest. 75:809-817.
19. Lucas, C.P., J.A. Estigarribia, L.L. Darga, and G.M. Reaven. 1985. Insulin and blood pressure in obesity. Hypertension. 7:702-706.
20. Ferrannini, E., G. Buzzigoli, R. Bonadonna, M.A. Giorico, M. Oleggini, L. Graziadei, R. Pedrinelli, L. Brandi, and S. Bevilacqua. 1987. Insulin resistance in essential hypertension. N. Engl. J. Med. 15:350-357.
21. Bonora, E., I. Zavaroni, O. Alpi, A. Pezzarossa, F. Bruschi, E. Dall'Aglio, L. Guerra, C. Coscelli, and U. Butturini. 1987. Relationship between blood pressure and plasma in insulin in non-obese and obese non-diabetic subjects. Diabetologia. 30:719-723.
22. Lillioja, S., A.A. Young, and C.L. Culter. 1987. Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. J Clin. Invest. 80:415-424.
23. Steinberg, H.O., G. Brechtel, A. Johnson, N. Fineberg, and A.D. Baron. 1994. Insulin mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J. Clin. Invest. 94:1172-1179.
24. DeFronzo, R.A. 1981. The effect of insulin on renal sodium metabolism: a review with clinical implications. Diabetologia. 21:165-171.
25. Rowe, J.W., J.B. Young, K.L. Minaker, A.L. Stevens, J. Pallotta, and L. Landsberg. 1981. Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes. 30:219-225.
26. Moore, R.D. 1483. Effects of insulin upon ion transport. Biochim. Biophys. Acta. 737:1-44.
27. Palmer, R.M.J., A.G. Ferrige, and S. Moncada. 1987. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 327:524-526.
28. Moncada, S., R.M.J. Palmer, and E.A. Higgs. 1991. Nitric oxide: physiology, pathology, and pharmacology. Pharmacol. Rev. 43:109-142.
29. Huang, P.L., Z. Huang, H. Mashimo, K.D. Bloch, M.A. Moskowitz, J.A. Bevan, and M.C. Fishman. 1995. Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature. 377:239-242.
30. Meraji, S., L. Jayakody, P.J. Senaratne, A.B.R. Thomson, and T. Kappagoda. 1987. Endolhelium-dependent relaxation in aorta of BB rat. Diabetes. 36: 978-981.
31. Kamata, K., N. Miyata, and Y. Kasuya. 1989. Impairment of endothelium-dependent relaxation and changes in levels of cyclic GMP in aorta from streptozotocin-induced diabetic rats. Br. J. Pharmacol. 97:614-618.
32. Howard, B.V. 1987. Lipoprotein metabolism in diabetes mellitus. J. Lipid Res. 28:613-628.
33. Reaven, E.P., and G.M. Reaven. 1974. Mechanisms for development of diabetic hypertriglyceridemia in streptozotocin-treated rat. Effect of diet and duration of insulin deficiency. J. Clin. Invest. 54:1167-1178.
34. Shimada, M., S. Ishibashi, T. Gotoda, M. Kawamura, K. Yamamoto, T. Inaba, K. Harada, J. Ohsuga, S. Perrey, Y. Yazaki, and N. Yamada. 1995. Overexpression of human lipoprotein lipase protects diabetic transgenic mice from diabetic hypertriglyceridemia and hypercholesterolemia. Arterioscler. Thromb. Vase. Biol. 15:1688-1694.
35. Eckel, R.H. 1989. Lipoprotein lipase: a multifunctional enzyme relevant to common metabolic diseases. N. Engl. J. Med. 320:1060-1068.
36. Ruderman, N.B., C.J. Toews, and E. Shafrir. 1969. Role of free fatty acids in glucose homeostasis. Arch. Intern. Med. 123:299-313.
37. Pelkonen, R., T.A. Miettinen, M.R. Taskinen, and E.A. Nikkila. 1968. Effect of acute elevation of plasma glycerol, triglyceride and FFA levels on glucose utilization and plasma insulin. Diabetes. 17:76-82.
38. Coppack, S.W., R.D. Evans, R.M. Fisher, K.N. Frayn, G.F. Gibbons, S.M. Humphreys, M.L. Kirk, J.L. Potts, and T.D.R. Hockaday. 1992. Adipose tissue metabolism in obesity: lipase action in vivo before and after a mixed meal. Metabolism. 41:264-272.
39. Lafontan, M., and M. Berlan. 1993. Fat cell adrenergic receptors and the control of white and brown fat cell function. J. Lipid Res. 34:1057-1091.